AMA Ed Hub Logo

Learn more on prescription drugs from AMA Ed Hub™
Red JAMA Logo

Learn more on prescription drugs from JAMA Network™
2025 Annual Meeting of the HOD

Learn more on prescription drugs from PolicyFinder
United States Adopted Names Council

United States Adopted Names (USAN)
Clear Search
·
1 Min Read

AMA urges EpiPen manufacturer to rein in exorbitant costs

"Statement attributable to: Andrew W. Gurman, M.D. President, American Medical Association"

Press Releases
·
6 Min Read

AMA guide for media reporting on "open payments" data release

Media should verify the accuracy of data; understand the context of financial relationships between physicians and industry when reporting on open payments data.

Press Releases
·
2 Min Read

Physicians confront the rise of “smart drugs”

Safety concerns generated by a growing use of nootropics prompted the AMA to adopt new policy discouraging the nonmedical use of these prescription drugs for cognitive enhancement in healthy individuals.

Behavioral Health
·
3 Min Read

AMA confronts the rise of nootropics

Responding to the growing personal use of nootropics, AMA physicians today adopted policy to discourage nonmedical use of drugs for cognitive enhancement.

Press Releases
·
2 Min Read

Medicare financial data going public: Review yours now

Physicians have until May 15 to review and dispute reports about financial interactions with manufacturers of drugs and medical devices reported under the the Open Payments program.

Medicare & Medicaid
National Advocacy Conference panel
·
5 Min Read

Experts explain high drug prices, offer solutions

Addressing the rising cost of prescription drugs, 3 experts in the pharmaceuticals field discuss marketplace trends affecting drug spending and pricing. They also discuss solutions to address drug prices and availability.

Behavioral Health
·
2 Min Read

AMA overview clarifies CME reporting under the Sunshine Act

The AMA has provided an overview that addresses concerns about reporting requirements and participation in commercially supported, accredited and certified continuing medical education (CME) programs in 2016.

Behavioral Health
·
3 Min Read

From Rx prices to EHRs: Top stories from the 2015 AMA Interim Meeting

The 2015 AMA Interim Meeting took place this week. Read these highlights from the meeting, and see AMA Wire's® full coverage of the event to learn more.

Interim Meeting
·
4 Min Read

Physicians call for fairness in drug prices, availability

In response to increasing drug costs impacting patient access to needed medications, physicians voted Monday at the 2015 Interim Meeting to convene a task force and launch an advocacy campaign to drive solutions and help make prescription drugs more affordable. Physicians also are calling for greater competition in the pharmaceutical industry and transparency in prescription drug prices and costs.

Behavioral Health